Amendment No. 4 to Product License and Distribution Agreement between NSI and Dell Computer Corporation

Summary

This amendment, effective July 25, 2003, modifies the existing Product License and Distribution Agreement between NSI and Dell Computer Corporation. For six months, Dell is permitted to sublicense and distribute one Double-Take for Windows license with each Dell CX200 shipped. Dell will pay NSI a specified fee for each license distributed. The license may only be used as a replication target on a single NAS or server attached to a CX200. The amendment is signed by authorized representatives of both companies.

EX-10.27 22 w23440a1exv10w27.htm EX-10.27 exv10w27  

Exhibit 10.27
AMENDMENT 4
Effective Date: July 25, 2003
This Amendment 4 becomes part of the PRODUCT LICENSE AND DISTRIBUTION (the “Agreement”), dated December 10, 2001, between NSI and Dell Computer Corporation (“Dell”). The term of this Amendment 4 is six (6) months from the effective date of this Amendment 4.
§       Whereas, NSI and Dell wish to modify certain provisions regarding NSI Products, the Agreement shall be modified as follows:
       The following should be added to Exhibit A — Licensed Software:
  §   Double-Take® for Windows
Each participating Dell Segment will be able to sublicense and distribute one (1) license of Double-Take® for Windows with each Dell CX200 that the participating Dell Segment ships. Dell shall pay NSI * for each Double-Take® for Windows license sublicensed and distributed under this Amendment #4 Such license can only be utilized as a target for replication on a single NAS or Server that is attached to a CX200.
                     
Network Specialists Inc.       Dell Computer Corporation    
 
                   
Date: 11/13/03       Date: 12/2/03    
 
Signature:
  /s/ Scott Meyers
 
      Signature:  /s/ Zita Cassizzi
 
   
 
Print Name: Scott Meyers       Print Name: Zita Cassizzi    
 
Title: COO       Title: Director S&P Marketing    
 
Fax Number: (201)  ###-###-####       Fax Number:    
 
             
 
   
 
*   Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933.
Page 1